Prognostic impact of MGMT promoter methylation and MGMT and CD133 expression in colorectal adenocarcinoma.

MLA

Oliver, Jaime Antonio, et al. “Prognostic Impact of MGMT Promoter Methylation and MGMT and CD133 Expression in Colorectal Adenocarcinoma.” BMC Cancer, vol. 14, July 2014, pp. 1–11. EBSCOhost, https://doi.org/10.1186/1471-2407-14-511.

APA

Oliver, J. A., Ortiz, R., Melguizo, C., Álvarez, P. J., Gómez-Millán, J., & Prados, J. (2014). Prognostic impact of MGMT promoter methylation and MGMT and CD133 expression in colorectal adenocarcinoma. BMC Cancer, 14, 1–11. https://doi.org/10.1186/1471-2407-14-511

Chicago

Oliver, Jaime Antonio, Raúl Ortiz, Consolación Melguizo, Pablo Juan Álvarez, Jaime Gómez-Millán, and Jose Prados. 2014. “Prognostic Impact of MGMT Promoter Methylation and MGMT and CD133 Expression in Colorectal Adenocarcinoma.” BMC Cancer 14 (July): 1–11. doi:10.1186/1471-2407-14-511.